Co-Authors
This is a "connection" page, showing publications co-authored by Hiroaki Mitsuya and Norio Ohmagari.
Connection Strength
1.346
-
Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan. J Infect. 2021 08; 83(2):237-279.
Score: 0.237
-
Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan. Glob Health Med. 2021 Apr 30; 3(2):90-94.
Score: 0.236
-
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies. J Infect Chemother. 2021 Jul; 27(7):1063-1067.
Score: 0.235
-
Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma. Sci Rep. 2021 03 10; 11(1):5563.
Score: 0.233
-
Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan. J Infect. 2021 04; 82(4):e1-e3.
Score: 0.232
-
Characterization of a new SARS-CoV-2 variant that emerged in Brazil. Proc Natl Acad Sci U S A. 2021 07 06; 118(27).
Score: 0.060
-
A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies. Sci Rep. 2021 03 04; 11(1):5198.
Score: 0.058
-
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U S A. 2020 07 14; 117(28):16587-16595.
Score: 0.056